Arteris, Inc. (NASDAQ:AIP – Get Free Report) CFO Nicholas B. Hawkins sold 3,770 shares of the stock in a transaction that occurred on Monday, June 9th. The shares were sold at an average price of $8.07, for a total value of $30,423.90. Following the sale, the chief financial officer now directly owns 161,937 shares of the company’s stock, valued at $1,306,831.59. The trade was a 2.28% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink.
Arteris Price Performance
Shares of Arteris stock opened at $8.29 on Wednesday. The company’s fifty day simple moving average is $6.92 and its two-hundred day simple moving average is $8.59. Arteris, Inc. has a 12-month low of $5.46 and a 12-month high of $12.64. The firm has a market cap of $348.00 million, a PE ratio of -9.53 and a beta of 1.37. The company has a quick ratio of 1.17, a current ratio of 1.17 and a debt-to-equity ratio of 0.30.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Quarry LP purchased a new stake in Arteris in the fourth quarter worth $46,000. GAMMA Investing LLC boosted its holdings in shares of Arteris by 11,823.3% during the 1st quarter. GAMMA Investing LLC now owns 5,127 shares of the company’s stock valued at $350,000 after buying an additional 5,084 shares in the last quarter. US Bancorp DE increased its stake in shares of Arteris by 29.0% in the 4th quarter. US Bancorp DE now owns 5,702 shares of the company’s stock worth $58,000 after acquiring an additional 1,283 shares in the last quarter. CWM LLC increased its stake in shares of Arteris by 4,810.1% in the 1st quarter. CWM LLC now owns 10,213 shares of the company’s stock worth $71,000 after acquiring an additional 10,005 shares in the last quarter. Finally, D. E. Shaw & Co. Inc. purchased a new position in Arteris during the 4th quarter valued at about $110,000. Hedge funds and other institutional investors own 64.36% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Analysis on Arteris
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
- Five stocks we like better than Arteris
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- D-Wave Is Soaring—But Is ETF Diversification the Better Strategy?
- How to buy stock: A step-by-step guide for beginners
- AppLovin Dips on S&P 500 Snub, Morgan Stanley Lifts Target Anyway
- Asset Allocation Strategies in Volatile Markets
- Casey’s Surges on Strong Q4, More Gains Likely Ahead
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.